This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Liver Transplantation
and you are
over 18
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

Tacrolimus pharmacokinetics study in primary living donor liver transplantation patients with Tacrolimus based immunosuppressive regimens.

Provided treatments

  • Drug: FK506E (modified release tacrolimus)
  • Drug: Prograf (tacrolimus)
Tris trial is registered with FDA with number: NCT00909571. The sponsor of the trial is Astellas Pharma Inc and it is looking for 10 volunteers for the current phase.
Official trial title:
A Phase 3 Pilot Study to Describe the Pharmacokinetics of Tacrolimus in Patients Undergoing Primary Liver Donor Liver Transplantation Treated With Prograf Injection and Modified Release Tacrolimus Based Immunosuppressive Regimen